Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Int J Tuberc Lung Dis ; 25(1): 36-42, 2021 01 01.
Article in English | MEDLINE | ID: mdl-33384043

ABSTRACT

BACKGROUND: Anti-TB drugs dosing based on weight alone may contribute to suboptimal drug concentrations and poor treatment outcomes in malnourished children. We examined the effect of malnutrition on the pharmacokinetics (PK) of first-line anti-TB drugs in children.METHODS: Drug concentrations were measured in Ghanaian children during the intensive phase of TB treatment. Weight-for-age (WFA), height-for-age (HFA), weight-for-height (WFH) and body mass index-for-age (BFA) were calculated and children with Z-scores < -2 SD (standard deviations) were considered as having malnutrition. PK differences of anti-TB drugs were compared by nutritional status.RESULTS: Of 100 participants, 24/48 (50.0%) of those younger than 5 years had wasting, 58/86 (67.4%) were underweight, and 56/99 (56.6%) had stunting; 22/51 (43.1%) children aged ≥5 years had low BFA. Children with stunting were more likely than controls to have lower mean peak concentration (Cmax) and area under the curve (AUC0-8h) of rifampin (RIF) and pyrazinamide (PZA), as well as a higher frequency of Cmax below the normal range. Wasting and underweight were associated with lower mean ethambutol (EMB) Cmax and AUC0-8h.CONCLUSIONS: The current WHO-recommended dosages were associated with lower plasma exposure of RIF, PZA and EMB in children with stunting, wasting and underweight. Anti-TB drugs dosing models for children may need to include height.


Subject(s)
Malnutrition , Pharmaceutical Preparations , Tuberculosis , Antitubercular Agents/therapeutic use , Child , Child, Preschool , Ghana/epidemiology , Humans , Malnutrition/epidemiology , Tuberculosis/drug therapy , Tuberculosis/epidemiology
3.
Chest ; 120(2): 343-8, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11502627

ABSTRACT

OBJECTIVE: To study the clinical characteristics and results of patients with diagnoses of multidrug-resistant tuberculosis (MDR-TB) in the state of Florida. METHODS: Retrospective chart review of all patients (n = 81) with diagnoses of MDR-TB in Florida between January 1, 1994, and July 31, 1997. RESULTS: The average number of resistant drugs was 4.8 (range, 2 to 11). Of 81 patients, 46 patients (57%) completed adequate therapy, 26 patients (32%) died, and 9 patients (11%) never completed a satisfactory course of treatment. Patients who received at least part of their therapy at A. G. Holley State Hospital, a specialized tuberculosis (TB) treatment center, had significantly higher treatment completion rates (79%) than those treated as outpatients alone (48% treatment completion rate, p < 0.001), even after the exclusion of patients who were acutely ill and died within 2 months of diagnosis. CONCLUSION: In Florida, a specialized TB care program for MDR-TB, including at least partial inpatient therapy, yielded higher treatment completion rates compared to outpatient treatment alone.


Subject(s)
Tuberculosis, Multidrug-Resistant/drug therapy , Adult , Ambulatory Care , Female , Florida , Humans , Inpatients , Male , Patient Compliance , Retrospective Studies , Treatment Outcome
4.
Chest ; 119(2): 640-2, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11171750

ABSTRACT

Several studies have shown that funeral directors have an increased risk of tuberculosis (TB). Although there is indirect evidence of transmission of TB from cadavers to mortuary workers, there is only one recently documented case in the literature. We report here another case of occupationally acquired TB in a funeral director, which was confirmed by conventional epidemiology and genotyping. This case illustrates the risk of TB transmission to mortuary workers from routine embalming of deceased TB patients with active disease.


Subject(s)
Embalming , Occupational Diseases/microbiology , Tuberculosis/transmission , Adult , Antibiotics, Antitubercular/pharmacology , DNA Fingerprinting , Drug Resistance, Microbial , Embalming/methods , Fatal Outcome , Humans , Male , Middle Aged , Mycobacterium tuberculosis/classification , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/isolation & purification , Rifampin/pharmacology , Tuberculosis/drug therapy
5.
Chest ; 117(5): 1455-73, 2000 May.
Article in English | MEDLINE | ID: mdl-10807837

ABSTRACT

Tuberculosis (TB) has been and continues to be one of the most significant pathogens in terms of human morbidity and mortality. Although the resurgence of TB has been held in check in most developed countries, the epidemic rages on in most developing countries of the world. The specter of drug resistance is becoming a more credible challenge in many parts of the world, dimming the prospects of eventual elimination. However, great opportunities are arising as well, with an unprecedented focus on the global aspects of TB control. This article will review the status of TB today and put into perspective the prospects for its elimination in the coming century.


Subject(s)
Developing Countries , Disease Outbreaks , Tuberculosis, Multidrug-Resistant/prevention & control , Tuberculosis, Pulmonary/prevention & control , Cause of Death , Cross-Cultural Comparison , Cross-Sectional Studies , Disease Outbreaks/statistics & numerical data , Forecasting , Humans , Incidence , Tuberculosis, Multidrug-Resistant/mortality , Tuberculosis, Pulmonary/mortality
SELECTION OF CITATIONS
SEARCH DETAIL
...